8-K: Ekso Bionics Grants Executive Equity Awards, Updates Severance

Ekso Bionics Holdings, Inc. announced new equity awards and updated severance agreements for three key executives to enhance retention and align with strategic goals.

Summary

• Ekso Bionics Holdings, Inc. granted equity awards to Scott Davis, Jerome Wong, and Jason Jones on November 5, 2025, under the Amended and Restated 2014 Equity Incentive Plan.
• Restricted Stock Units (RSUs) were granted as follows: Scott Davis (80,000 shares), Jerome Wong (19,500 shares), and Jason Jones (15,000 shares). These RSUs were fully vested as of the grant date.
• Phantom Performance-Based Restricted Stock Units (Phantom PSUs) were also granted: Scott Davis (185,000 notional shares), Jerome Wong (40,000 notional shares), and Jason Jones (32,000 notional shares).
• Phantom PSUs vest upon the achievement of two performance requirements within a five-year period from the grant date: the occurrence of a Change in Control and the achievement of a Stock Price of at least $7.50, subject to continuous employment.
• Upon vesting, Phantom PSUs will be settled in cash, not shares of common stock.
• New Change in Control and Severance Agreements were entered into with each executive on November 5, 2025, superseding prior severance understandings.
• For a termination without Cause outside a Change in Control period, Scott Davis will receive 9 months of base salary, while Jerome Wong and Jason Jones will each receive 6 months of base salary.
• In the event of a termination without Cause or resignation for Good Reason within 12 months following a Change in Control, Scott Davis will receive a lump sum payment of 18 months base salary, 18 months of COBRA coverage payments/reimbursements, and full vesting acceleration for time-based equity awards.
• For the same Change in Control scenario, Jerome Wong and Jason Jones will each receive a lump sum payment of 9 months base salary, 9 months of COBRA coverage payments/reimbursements, and full vesting acceleration for time-based equity awards.
• Severance payments are contingent upon the executive signing and not revoking a release of claims, returning company property, and resigning from officer/director positions.

Sentiment

Score: 7

Explanation: The filing outlines compensation structures designed to align executive incentives with shareholder value creation and retention, which is generally positive for long-term strategic execution. However, it also represents future compensation liabilities and potential significant payouts under specific conditions.

Positives

• The equity awards and severance agreements are designed to enhance executive retention and motivate them to achieve strategic goals and drive stockholder growth.
• Performance-based Phantom PSUs align executive incentives directly with shareholder value creation through a stock price goal of $7.50 and a Change in Control event.
• The immediate vesting of RSUs provides a direct and immediate incentive for the executives.
• The severance agreements provide competitive protections for executives in various termination scenarios, which can help attract and retain high-caliber talent.

Negatives

• The Phantom PSUs, while performance-based, represent a future cash liability for the company upon vesting.
• The severance packages, particularly in a Change in Control scenario, could result in significant cash outflows and accelerated equity vesting, potentially impacting company finances.
• The fully vested RSUs represent an immediate compensation expense and potential dilution if settled in shares (though these are RSUs, not options, so the shares are already accounted for in the plan).

Risks

• The company disclaims liability for any taxes, penalties, interest, or other expenses incurred by the Grantee due to non-compliance with Section 409A of the Code, placing this risk on the executives.
• Payments under severance agreements may be subject to excise taxes under Sections 280G and 4999 of the Internal Revenue Code, although the agreements include a provision to reduce payments if it results in a better after-tax outcome for the executive.
• Unvested PSUs are forfeited if continuous employment terminates for any reason before vesting, or if performance requirements are not met within the five-year period.

Future Outlook

The equity awards, particularly the Phantom PSUs, are explicitly designed to motivate executives to drive stockholder growth and achieve the company's strategic goals, with a clear stock price target of $7.50 and the potential for a Change in Control within five years.

Management Comments

• The board of directors approved these equity awards to assist in retention and to help motivate each executive to drive stockholder growth and achieve the company's strategic goals.

Industry Context

These compensatory arrangements, including performance-based equity awards and change in control severance provisions, are standard practices in the publicly traded company landscape. They are commonly used to align executive incentives with shareholder interests, retain key talent, and provide stability during potential corporate transitions like mergers or acquisitions.

Comparison to Industry Standards

• The structure of these equity awards, combining immediately vested RSUs with performance-based PSUs tied to a stock price goal and a change in control, is a common approach to executive compensation in growth-oriented technology or medical device companies like Ekso Bionics.
• The severance benefits, offering 6-9 months of salary for non-CIC terminations and 9-18 months of salary plus COBRA and equity acceleration for CIC terminations, are generally within the competitive range for executives at companies of similar size and market capitalization, aiming to provide security and prevent executive flight during M&A discussions.
• The inclusion of a 'best results amount' clause to mitigate excise taxes under Sections 280G and 4999 of the Code is a standard protective measure often seen in executive severance agreements to optimize after-tax outcomes for executives.

Corporate Governance

Related Party Transactions

• The equity award grants and severance agreements are transactions between the company and its key executives (Scott Davis, Jerome Wong, Jason Jones), which are considered related party transactions in the context of executive compensation.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value if executives achieve the $7.50 stock price goal and strategic objectives. However, there is also potential for dilution from RSU grants (if settled in shares, though PSUs are cash-settled) and the cost associated with executive compensation and severance packages.
• Employees: Retention of key executives can provide stability and leadership, potentially benefiting overall employee morale and company direction.
• Executives: Receive significant equity incentives tied to performance and retention, along with enhanced severance protections, providing financial security and motivation.

Next Steps

• Executives will continue to render services to the company, aiming to achieve the performance requirements for PSU vesting, including a Change in Control and a Stock Price of at least $7.50 within five years.
• The company will administer the vesting and settlement of PSUs in cash upon the achievement of performance conditions and continuous employment.
• In the event of a qualifying termination, the company will process severance payments and benefits according to the new agreements, subject to the executive's compliance with conditions like signing a release of claims.

Key Dates

Keywords

Ekso Bionics, EKSO, equity incentive plan, restricted stock units, performance stock units, executive compensation, severance agreement, change in control, corporate governance, retention, stock price goal